Evidence map›Paper›PMID 39106033›Full record

ArticleNeurology and therapy2024

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.

Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d'Onofrio, Cinzia Aurilia, Cinzia Finocchi, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina and 23 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Piero BarbantiHeadache and Pain Unit, IRCCS San Raffaele, Via Della Pisana 235, 00163, Rome, Italy. piero.barbanti@sanraffaele.it.ORCID http://orcid.org/0000-0002-5670-3755
Gabriella EgeoHeadache and Pain Unit, IRCCS San Raffaele, Via Della Pisana 235, 00163, Rome, Italy.
Stefania ProiettiClinical and Molecular Epidemiology, IRCCS San Raffaele, Rome, Italy.
Florindo d'OnofrioNeurology Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
Cinzia AuriliaHeadache and Pain Unit, IRCCS San Raffaele, Via Della Pisana 235, 00163, Rome, Italy.
Cinzia FinocchiNeurology Unit, San Paolo Hospital, ASL 2, Savona, Italy.
Laura Di ClementeHeadache Center, Neurology Unit, San Camillo-Forlanini Hospital, Rome, Italy.
Maurizio ZuccoHeadache Center, Neurology Unit, San Camillo-Forlanini Hospital, Rome, Italy.
Alberto DorettiLaboratory of Neuroscience, Department of Neurology-Stroke Unit, Istituto Auxologico Italiano, IRCCS, Milano, Italy.
Stefano MessinaLaboratory of Neuroscience, Department of Neurology-Stroke Unit, Istituto Auxologico Italiano, IRCCS, Milano, Italy.
Massimo AutunnoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Angelo RanieriNeurology Unit and Stroke-Unit, AORN A. Cardarelli, Naples, Italy.
Antonio CarnevaleHeadache Center, Neurology Unit, San Filippo Neri Hospital, Rome, Italy.
Bruno ColomboDepartment of Neurology, Headache Unit, Scientific Institute San Raffaele Hospital, Vita-Salute University, Milan, Italy.
Massimo FilippiDepartment of Neurology, Headache Unit, Scientific Institute San Raffaele Hospital, Vita-Salute University, Milan, Italy.
Miriam TasilloStroke Unit, S. Camillo de Lellis Hospital, Rieti, Italy.
Steno RinalduzziStroke Unit, S. Camillo de Lellis Hospital, Rieti, Italy.
Pietro QuerzaniNeurology Unit, S. Maria Delle Croci Hospital-AUSL Romagna, Ravenna, Italy.
Giuliano SetteDepartment of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sant'Andrea University Hospital, "Sapienza" University of Rome, Rome, Italy.
Lorenzo ForinoNeurology Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
Francesco ZorodduNeurology Unit, Pediatric Headache Center, University of Sassari, Sassari, Italy.
Micaela RobottiHeadache Center, ASST Santi Paolo Carlo, Milan, Italy.
Alessandro ValenzaHeadache Center, UOC Neurology, Ospedale Belcolle, Viterbo, Italy.
Cecilia CamardaDepartment of Biomedicine, Neurosciences, and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Laura BorrelloFrosinone Hospital, Headache Center, Frosinone, Italy.
Marco AguggiaNeurology and Stroke Unit, Cardinal Massaia Hospital, Asti, Italy.
Giovanna ViticchiNeurological Clinic, Marche Polytechnic University, Ancona, Italy.
Carlo TominoScientific Direction IRCCS San Raffaele, Rome, Italy.
Giulia FiorentiniSan Raffaele University, Rome, Italy.
Bianca OrlandoHeadache and Pain Unit, IRCCS San Raffaele, Via Della Pisana 235, 00163, Rome, Italy.
Stefano BonassiClinical and Molecular Epidemiology, IRCCS San Raffaele, Roma, Italy.
Paola TorelliDepartment of Medicine and Surgery, Headache Center, Neurology Unit, University of Parma, Parma, Italy.
Italian Migraine Registry study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39106033
PMCPMC11393228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.